https://orcid.org/0000-0003-3223-2597
References
- Wiest MD, Suda KJ, Rim MH, et al. National trends in prescription drug expenditures and projections for 2019. Am J Health Syst Pharm. 2019;76(15):1105–1121. doi:10.1093/ajhp/zxz109
- Centers for Medicare & Medicaid Services, Medicare Part B Drug Spending Dashboard & Data. Available from: https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/Information-on-Prescription-Drugs/MedicarePartB. Accessed December 1, 2020.
- Centers for Medicare & Medicaid Services, Medicare Part D Drug Spending Dashboard & Data. Available from: https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/Information-on-Prescription-Drugs/MedicarePartD. Accessed December 1, 2020.
- Anhang Price R, Sloss EM, Cefalu M, Farmer CM, Hussey PS. Comparing Quality of Care in Veterans Affairs and Non-Veterans Affairs Settings. J Gen Intern Med. 2018;33(10):1631–1638. doi:10.1007/s11606-018-4433-7
- Aspinall SL, Sales MM, Good CB, et al. Pharmacy Benefits Management in the Veterans Health Administration Revisited: a Decade of Advancements, 2004–2014. J Manag Care Spec Pharm. 2016;22(9):1058–1063. doi:10.18553/jmcp.2016.22.9.1058
- United States Department of Veterans Affairs, Veterans Health Administration. Available from: https://www.va.gov/health/aboutvha.asp#:~:text=The%20Veterans%20Health%20Administration%20(VHA,Veterans%20enrolled%20in%20the%20VA). Accessed December 1, 2020.
- Military Health System. Available from: https://www.health.mil/I-Am-A/Media/Media-Center/Patient-Population-Statistics/Patients-by-Beneficiary-Category. Accessed December 1, 2020.
- Centers for Medicare & Medicaid Services, Medicare Part B Discarded Drug Units Report. Available from: https://www.cms.gov/research-statistics-data-systems/cms-drug-spending/medicare-part-b-discarded-drug-units-report. Accessed December 1, 2020.
- Benecke R, Jost WH, Kanovsky P, Ruzicka E, Comes G, Grafe S. A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia. Neurology. 2005;64(11):1949–1951. doi:10.1212/01.WNL.0000163767.99354.C3
- Roggenkämper P, Jost WH, Bihari K, Comes G, Grafe S. NT 201 Blepharospasm Study Team. Efficacy and safety of a new botulinum toxin type A free of complexing proteins in the treatment of blepharospasm. J Neural Transm. 2006;113(3):303–312. doi:10.1007/s00702-005-0323-3
- Merz Pharmaceuticals, LLC. Prescribing Information: xeomin®. Available from: https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=ccdc3aae-6e2d-4cd0-a51c-8375bfee9458&type=display. Accessed December 1, 2020.
- Kazerooni R, Broadhead C. Cost-utility analysis of botulinum toxin type A products for the treatment of cervical dystonia. Am J Health Syst Pharm. 2015;72(4):301–307. doi:10.2146/ajhp140276
- Karschney VK, Greeley DR, Retrospective Cost A. Analysis of Patients Who Switched from OnabotulinumtoxinA to IncobotulinumtoxinA in a Private Neurology Practice. Am Health Drug Benefits. 2020;13:5.
- Merz Pharmaceuticals, LLC Data Warehouse. Federal purchase data 2014-2019. [Data file]. Raleigh: Data Analytics;2020.
- Office of Acquisition, Logistics, and Construction. Accessed from: https://www.va.gov/oalc/foia/library.asp. Accessed December 1, 2020.
- Department of Veterans Affairs, Pharmacy Benefits Management (PBM) Services. Available from: https://www.va.gov/opal/docs/nac/fss/pl102585-2021pbmDearMfrLetter.pdf. Accessed December 1, 2020.
- Congressional Research Service. Available from: https://www.everycrsreport.com/files/20070413_RL33802_b2eae76c0e50dfeda595e4b627298b326046453b.pdf. Accessed December 1, 2020.
- Carias C, Chesson HW, Grosse SD, et al. Recommendations of the Second Panel on Cost Effectiveness in Health and Medicine: a Reference, Not a Rule Book. Am J Prev Med. 2018;54(4):600–602. doi:10.1016/j.amepre.2017.11.013
- Allergan, Inc. Prescribing Information: botox®. Available from: https://media.allergan.com/actavis/actavis/media/allergan-pdf-documents/product-prescribing/20190620-BOTOX-100-and-200-Units-v3-0USPI1145-v2-0MG1145.pdf. Accessed December 1, 2020.
- U.S. Bureau of Labor Statistic Consumer Price Index. Available from: https://www.bls.gov/data/inflation_calculator.htm. Accessed December 1, 2020.
- Kazerooni R, Watanabe JH. Comparison of botulinum toxins for treatment of movement disorders: real-world utilization and cost analysis in a national Medicare population. J Manag Care Spec Pharm. 2021;27(4):478–487. doi:10.18553/jmcp.2021.20346
- Spencer SH, Suda KJ, Smith BM, Huo Z, L Jr B, Stroupe KT. Erectile Dysfunction Medication Use in Veterans Eligible for Medicare Part D. J Manag Care Spec Pharm. 2016;22(7):818–824. doi:10.18553/jmcp.2016.22.7.818